Federal Register / Vol. 60, No. 81 / Thursday, April 27, 1995 / Notices 20751

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Joint Research and

Development Venture Agreement for

Seismic Technology

Notice is hereby given that, on

February 10, 1995, pursuant to the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), Paul W.

Pendorf, President of XXsys

Technologies, Inc. has filed written

notifications simultaneously with the

Attorney General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are: XXsys Technologies, Inc./

Composite Retrofit Corp., San Diego,

CA; Hercules Incorporated, Wilmington,

DE; and Trans-Science Corp., La Jolla,

CA. The general area of planned activity

is to develop and demonstrate low cost

manufacturing process and design/

sensor technologies for seismic

upgrading of bridge columns. An award

from the Advanced Technology

Program, National Institute of Standards

and Technology, U.S. Department of

Commerce will partially fund this joint

Research and Development Activity.

Constance K. Robinson,

Director of Operations Antitrust Division.

[FR Doc. 95–10312 Filed 4–26–95; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Gas Pipeline Monitoring

for Third-Party Damage

Notice is hereby given that, on

February 21, 1995, pursuant to section

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. § 4301 et seq. (‘‘the Act’’),

Southwest Research Institute (‘‘SwRI’’)

has filed written notifications

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing (1) the identities

of the parties and (2) the nature and

objectives of the venture. The

notifications were filed for the purpose

of invoking the Act’s provisions limiting

the recovery of antitrust plaintiffs to

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are: Tokyo Gas Company, LTD.,

Yokohama JAPAN; Osaka Gas Company,

Ltd., Osaka, JAPAN; and Toho Gas

Company, Ltd., Nagoya JAPAN. The

general areas of planned activities are to

determine what technologies are

available for monitoring of damage to

gas pipelines by conducting a literature

survey concerning detection of thirdparty damage to pipelines, sensing

systems being utilized and signal

processing technologies available in

order to advise the participants of such

a system’s detection capabilities to

display the location of damage, to

announce the detection of damage, and

to indicate the grade or degree of

damage which has occurred; by

exploring related detected technologies

and by evaluating the information

gathered in order to recommend one or

more technical approaches for further

research and system development.

Membership in the program is closed

and SwRI intends to file additional

written notification if there are any

changes in planned activities.

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–10314 Filed 4–26–95; 8:45 am]

BILLING CODE 4410–01–M

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—Petroleum Environmental

Research Forum

Notice is hereby given that, on March

1, 1995, pursuant to Section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C.

§ 4301 et seq. (‘‘the Act’’), the Petroleum

Environmental Research Forum

(‘‘PERF’’) has filed written notification

simultaneously with the Attorney

General and the Federal Trade

Commission disclosing a change in

project membership. The notifications

were filed for the purpose of extending

the Act’s provisions limiting the

recovery of antitrust plaintiffs to actual

damages under specified circumstances.

Specifically, Murphy Oil USA, Inc., has

terminated its membership with PERF.

No other changes have been made in

either the membership or planned

activities of PERF. Membership remains

open, and PERF intends to file

additional written notification

disclosing all changes in membership.

On February 10, 1986, PERF filed its

original notification pursuant to Section

6(a) of the Act. The Department of

Justice published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on March 14, 1986 (51 FR 8903).

The last notification was filed with

the Department on January 10, 1995. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on March 1, 1995 (60 FR 11115).

Constance K. Robinson,

Director of Operations, Antitrust Division.

[FR Doc. 95–10311 Filed 4–26–95; 8:45 am]

BILLING CODE 4410–01–M

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Application

Pursuant to § 1301.43(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on February 24, 1995,

Johnson Matthey, Inc., Custom

Pharmaceuticals Department, 2003

Nolte Drive, West Deptford, New Jersey

08066, made application to the Drug

Enforcement Administration (DEA) for

registration as a bulk manufacturer of

the basic classes of controlled

substances listed below:

Drug Schedule

2,5-Dimethoxyamphetamine

(7396).

I.

Difenoxin (9168) ........................... I.

Methylphenidate (1724) ............... II.

Codeine (9050) ............................ II.

Oxycodone (9143) ....................... II.

Hydromorphone (9150) ................ II.

Diphenoxylate (9170) ................... II.

Hydrocodone (9193) .................... II.

Levorphanol (9220) ...................... II.

Meperidine (9230) ........................ II.

Meperidine intermediate-A (9232) II.

Meperidine intermediate-B (9233) II.

Meperidine intermediate-C (9234) II.

Methadone (9250) ........................ II.

Methadone intermediate (9254) ... II.

Morphine (9300) ........................... II.

Oxymorphone (9652) ................... II.

Alfentanil (9737) ........................... II.

Sufentanil (9740) .......................... II.

Carfentanil (9743) ........................ II.

Fentanyl (9801) ............................ II.

The firm plans to manufacture the

listed control substances in bulk supply

final dosage form for manufacturers.

Any other such applicant and any

person who is presently registered with

DEA to manufacture such substances

may file comments or objections to the

issuance of the above application and

may also file a written request for a

hearing thereon in accordance with 21

CFR 1301.54 and in the form prescribed

by 21 CFR 1316.47.

Any such comments, objections, or

requests for a hearing may be addressed

to the Deputy Assistance Administrator,

Office of Diversion Control, Drug

Enforcement Administration, United

States Department of Justice,

Washington, D.C. 20537, Attention: DEA

Federal Register Representative (CCR),

and must be filed no later than May 30,

1995.
20752 Federal Register / Vol. 60, No. 81 / Thursday, April 27, 1995 / Notices

Dated: April 14, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–10286 Filed 4–26–95; 8:45 am]

BILLING CODE 4410–09–M

Importer of Controlled Substances;

Notice of Registration

By Notice dated February 17, 1995,

and published in the Federal Register

on March 1, 1995, (60 FR 11116), Lonza

Riverside, 900 River Road,

Conshohocken, Pennsylvania 19428,

made application to the Drug

Enforcement Administration to be

registered as an importer of

Phenylacetone (8501), as basic class of

controlled substance listed in Schedule

II.

No comments or objections have been

received. Therefore, pursuant to section

1008(a) of the Controlled Substances

Import and Export Act and in

accordance with Title 21, Code of

Federal Regulations, § 1311.42, the

above firm is granted registration as an

importer of the basic class of controlled

substance listed above.

Dated: April 10, 1995.

Gene R. Haislip,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 95–10287 Filed 4–26–95; 8:45 am]

BILLING CODE 4410–09–M

Information Collections Under Review

The Office of Management and Budget

(OMB) has been sent the following

collection(s) of information proposals

for review under the provisions of the

Paperwork Reduction Act (44 USC

Chapter 35) and the Paperwork

Reduction Reauthorization Act since the

last list was published. Entries are

grouped into submission categories,

with each entry containing the

following information:

(1) The title of the form/collection;

(2) The agency form number, if any,

and the applicable component of the

Department sponsoring the collection.

(3) Who will be asked or required to

respond, as well as a brief abstract;

(4) An estimate of the total number of

respondents and the amount of time

estimated for an average respondent to

respond;

(5) An estimate of the total public

burden (in hours) associated with the

collection; and,

(6) An indication as to whether

Section 3504(h) of Public Law 96–511

applies.

Comments and/or suggestions

regarding the item(s) contained in this

notice, especially regarding the

estimated public burden and associated

response time, should be directed to the

OMB reviewer, Mr. Jeff Hill on (202)

395–7340 and to the Department of

Justice’s Clearance Officer, Mr. Robert B.

Briggs, on (202) 514–4319. If you

anticipate commenting on a form/

collection, but find that time to prepare

such comments will prevent you from

prompt submission, you should notify

the OMB reviewer and the Department

of Justice Clearance Officer of your

intent as soon as possible. Written

comments regarding the burden

estimate or any other aspect of the

collection may be submitted to Office of

Information and Regulatory Affairs,

Office of Management and Budget,

Washington, DC 20503, and to Mr.

Robert B. Briggs, Department of Justice

Clearance Officer, Systems Policy Staff/

Information Resources Management/

Justice Management Division Suite 850,

WCTR, Washington, DC 20530.

Revision of a Currently Approved

Collection

(1) Employment Authorization

Document.

(2) Form I–765. Immigration and

Naturalization Service, United States

Department of Justice.

(3) Primary = Individuals or

households. Others = None. The

information collected on this form will

be used solely by the Immigration and

Naturalization Service to determine

eligibility for evidence of an

employment authorization document

pursuant to regulatory authority under 8

CFR 274 a. 12.

(4) 1,000,000 annual respondents at

3.416 hours per response.

(5) 3,416,000 annual burden hours.

(6) Not applicable under Section

3504(h) of Public Law 96–511.

Public comment on this item is

encouraged.

Dated: April 18, 1995.

Robert B. Briggs,

Department Clearance Officer, United States

Department of Justice.

Impact Statement

These revised instructions are being

published to alert the applicant of

modifications to current filing

procedures for the INS Form I–765. In

the past, many aliens were required to

be physically present in an INS office

for production of the employment

authorization document. At that time an

immigration official would take the

necessary photographs, obtain the

applicant’s signature, and physically

look at other documents to ensure

eligibility for employment

authorization.

Under this new filing procedure 75%

(percent) of applicants will now be able

to mail in their applications, and

photographs along with copies of

relating documents in support of the

request for employment authorization

into an INS central location for

processing.

This process should improve

efficiency of the I–765 process, improve

the delivery of services to the applicant

(public), maximize resources, tighten

inventory control, and ensure increased

security and the integrity of EAD

production.

We believe that these new guidelines

provide clear directions to applicants

concerning who can file, how to file,

where to file and when to file their

applications for employment

authorization documents.

BILLING CODE 4410–10–M